David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CALL
Procter & Gamble
PG
$336B
| $75M | 0.1% |
721,100
+300
| +0% | +$29.2K |
|
252
PUT
Lamb Weston
LW
$7.38B
| $74.9M | 0.1% |
+1,000,000
| New | +$70.8M |
|
253
CALL
JD.com
JD
$39.7B
| $74.9M | 0.1% |
2,485,200
+1,648,400
| +197% | +$41.9M |
|
254
NetApp
NTAP
$37.7B
| $74.6M | 0.1% |
1,075,440
+237,664
| +28% | +$15.3M |
|
|
WP
255
DELISTED
Worldpay, Inc.
WP
| $74.5M | 0.1% |
656,096
+646,534
| +6,761% | +$58.6M |
|
|
AABA
256
DELISTED
Altaba Inc
AABA
| $74M | 0.1% |
997,901
-314,451
| -24% | -$21.7M |
|
257
Air Products & Chemicals
APD
$67.9B
| $74M | 0.1% |
387,310
-90,871
| -19% | -$15.6M |
|
258
Chevron
CVX
$403B
| $73.9M | 0.1% |
600,028
-510,632
| -46% | -$60.4M |
|
259
Lockheed Martin
LMT
$130B
| $73.8M | 0.1% |
245,972
-424,032
| -63% | -$124M |
|
260
Bruker
BRKR
$9.07B
| $73.1M | 0.09% |
1,901,283
-232,090
| -11% | -$8.38M |
|
261
Hyatt Hotels
H
$17B
| $72.8M | 0.09% |
1,003,339
-220,822
| -18% | -$15.7M |
|
262
CALL
Caterpillar
CAT
$381B
| $72.7M | 0.09% |
536,600
-131,100
| -20% | -$17.4M |
|
263
Petrobras
PBR
$123B
| $71.8M | 0.09% |
4,511,233
+4,410,184
| +4,364% | +$70M |
|
|
264
PUT
AbbVie
ABBV
$468B
| $71.5M | 0.09% |
886,900
+345,200
| +64% | +$28.2M |
|
265
Take-Two Interactive
TTWO
$44.8B
| $71.3M | 0.09% |
756,023
+734,091
| +3,347% | +$71.2M |
|
266
Crown Castle
CCI
$32.1B
| $71.3M | 0.09% |
556,957
-454,759
| -45% | -$53.3M |
|
|
FLIR
267
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $70.8M | 0.09% |
1,487,192
-173,339
| -10% | -$8.38M |
|
268
Southwest Airlines
LUV
$19.8B
| $70.3M | 0.09% |
1,354,212
+325,130
| +32% | +$17.2M |
|
269
Humana
HUM
$45.5B
| $70.2M | 0.09% |
264,042
+90,622
| +52% | +$26.1M |
|
270
CALL
Adobe
ADBE
$109B
| $70.2M | 0.09% |
263,500
+178,500
| +210% | +$45M |
|
|
ZNGA
271
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $70.2M | 0.09% |
13,168,696
-451,176
| -3% | -$2.17M |
|
272
Host Hotels & Resorts
HST
$15.9B
| $70.2M | 0.09% |
3,711,898
+1,219,513
| +49% | +$22.5M |
|
|
273
CALL
Starbucks
SBUX
$122B
| $70.1M | 0.09% |
942,300
+256,200
| +37% | +$17.6M |
|
274
Ubiquiti
UI
$33.8B
| $69.9M | 0.09% |
466,641
+440,667
| +1,697% | +$55.6M |
|
275
Ross Stores
ROST
$76.7B
| $69.8M | 0.09% |
749,349
+645,821
| +624% | +$59.3M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.